Rituximab Maintenance Therapy for Granulomatosis with Polyangiitis and Microscopic Polyangiitis

Abstract

Rituximab maintenance therapy was well tolerated but did not completely prevent relapses and persistent "grumbling" disease. These preliminary results remain to be confirmed by a randomized controlled trial currently in progress.